These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12218569)

  • 21. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.
    Slomovitz BM; Caputo TA; Gretz HF; Economos K; Tortoriello DV; Schlosshauer PW; Baergen RN; Isacson C; Soslow RA
    Am J Surg Pathol; 2002 May; 26(5):592-600. PubMed ID: 11979089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
    Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
    J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology.
    Dietel M; Hauptmann S
    Virchows Arch; 2000 May; 436(5):403-12. PubMed ID: 10881733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.
    Smith Sehdev AE; Sehdev PS; Kurman RJ
    Am J Surg Pathol; 2003 Jun; 27(6):725-36. PubMed ID: 12766576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grading ovarian serous carcinoma using a two-tier system.
    Malpica A; Deavers MT; Lu K; Bodurka DC; Atkinson EN; Gershenson DM; Silva EG
    Am J Surg Pathol; 2004 Apr; 28(4):496-504. PubMed ID: 15087669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.
    Crispens MA; Bodurka D; Deavers M; Lu K; Silva EG; Gershenson DM
    Obstet Gynecol; 2002 Jan; 99(1):3-10. PubMed ID: 11777502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.
    Lee KR; Castrillon DH; Nucci MR
    Int J Gynecol Pathol; 2001 Oct; 20(4):329-34. PubMed ID: 11603215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micropapillary serous carcinoma of the ovary: case report and review of literature.
    Piura B; Rabinovich A; Yanai-Inbar I
    Eur J Gynaecol Oncol; 2000; 21(4):374-6. PubMed ID: 11055486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage IV micropapillary serous ovarian carcinoma: a report of three cases.
    Kim YW; Srodon M; Bristow RE
    Int J Gynecol Pathol; 2005 Jul; 24(3):235-8. PubMed ID: 15968198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
    Dehari R; Kurman RJ; Logani S; Shih IeM
    Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the landscape of ovarian serous borderline tumors.
    Messini I; Doulgeraki T; Chrysanthakis D; Yiannou P; Gavresea T; Papadimitriou C; Panoskaltsis T; Voulgaris Z; Vlachos A; Pavlakis K
    Int J Gynecol Cancer; 2019 Mar; 29(3):572-578. PubMed ID: 30659030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
    Shvartsman HS; Sun CC; Bodurka DC; Mahajan V; Crispens M; Lu KH; Deavers MT; Malpica A; Silva EG; Gershenson DM
    Gynecol Oncol; 2007 Jun; 105(3):625-9. PubMed ID: 17320156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.